TTT des cancers Flashcards

1
Q

Effets secondaires stochastiques et déterministes de la radiothérapie

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gérer les corticoïdes

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cisplatine

A

+ + Vésicante

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chimios vésicantes

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Oxaliplatine

A

“Oh qu’ça pèle dehors”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Carboplatine

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anthracyclines

A

= Inhibiteurs des topo-isomérases II
“Entre” = écrase une lame (LAM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Paclitaxel

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Docetaxel

A

Rappeur Dosseh
* Assis sur le trône = diarrhée, NEUTROpénie (tro-neu)
* Chevilles qui gonflent = œdèmes, épanchements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Gemcitabine

A

Gemcitabine = binouse
“T’es dans un bar, coupe la radio ! MATe la meuf là-bas ! Sue pas frérot ! Bois ta bière

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Les anti-métabolites

A

= classe de chimio

  • Gemcitabine
  • 5-fluorouracile (capécitabine = forme orale du 5-FU)
  • Méthotrexate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

5-FU

A
  • Sd mains-pieds : “5 doigts, 5 orteils”
  • Mucite : “tu mets tes mains/pieds dans la bouche”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Déficit en DHPD

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Méthotrexate

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cyclophosphamide

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inhibiteurs des topo-isomérases

A
17
Q

Irinotécan

A
18
Q

Etoposide

A
19
Q

Bléomycine

A
20
Q

Principales toxicités des chimios

A
21
Q

Sd de lyse tumorale

A
22
Q

Thérapies ciblées VS immunothérapie

A